Stanford Depression Research Clinic Currently Recruiting for ASCERTAIN-TRD Study

Augmentation versus Switch: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-Responders with Treatment Resistant Depression (ASCERTAIN-TRD)

The Stanford Depression Research Clinic is seeking people with major depressive disorder (MDD) to participate in a new research study.  If you are between the ages of 18 and 80, currently depressed, and have a history of trying at least one antidepressant medication, you may be eligible.

This study involves comparing three treatment arms:

• Adding Abilify to current antidepressant medication
• Adding Repetitive Transcranial Magnetic Stimulation (rTMS) to current antidepressant medication
• Switching your current antidepressant medication to Effexor Extended Release or Cymbalta

These three treatments are approved by the FDA to treat TRD. If enrolled, this study involves 9 visits over 12 weeks.

If you are currently taking an antidepressant medication that is only partially helping your depression, please fill out our online survey or email depressionresearch@med.stanford.edu.

For further details, please see the following link: https://clinicaltrials.gov/ct2/show/NCT02977299